Stratasys expands presence in medical sector through partnership with Encee

Medical technology Stratasys expands presence in medical sector through partnership with Encee

2023-11-29 Source: Stratasys 1 min Reading Time

Related Vendors

Stratasys GmbH

creaform-ametek-logos-vertical-rgb (Creaform)

AMETEK GmbH Division Creaform Deutschland

CUMSA

AMPCO METAL Deutschland GbmH

Stratasys is expanding its collaboration with Encee in Germany by establishing Encee Medical, a dedicated division focused on distributing Stratasys' medical solutions.

Stratasys announced its intent to expand its relationship with Encee.(Source: free licensed / Pixabay) — Stratasys announced its intent to expand its relationship with Encee.
(Source: free licensed / Pixabay)

3D printing company Stratasys has announced plans to expand its relationship with Encee, an established Stratasys Platinum Partner based in Germany. Under the terms of the new agreement, the partner will establish a dedicated division called Encee Medical to meet the growing needs of the medical sector in Germany.

Operating under the trade name Stratasys Medical, Encee Medical's primary focus will be to distribute Stratasys' medical solutions throughout Germany. This strategic partnership includes a significant expansion of Encee's hardware, training and service capabilities, as well as the recruitment of a specialised medical team.

Encee Medical, trading as Stratasys Medical, will be headquartered in Ursensollen, Bavaria, and will be equipped with state-of-the-art technology, including medical 3D printers, post-processing machines, a clinical workflow training centre and a skilled technical staff. Within this facility, Encee Medical dba Stratasys Medical will demonstrate the complete medical production workflow to potential and existing customers. The facility in Ursensollen, Bavaria, will also manufacture medical benchmarks and production components for medical customers and provide the necessary technical support.

“Our partnership with Encee will open new avenues for Stratasys in the German market,” said Scott Drikakis, Global Medical Segment Leader, Stratasys. “This agreement ensures the German medical market has access to world class polymer AM equipment, materials, post processing solutions and software solutions for an end-to-end medical workflow. Stratasys prides itself on its focus and commitment to the customer experience and is proud to offer this to the robust medical market in Germany.”

(ID:49813813)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Date: 08.12.2025

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.